• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/55

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

55 Cards in this Set

  • Front
  • Back
1. What is the mechanism of injury in acute viral hepatitis?
a. Direct cytotoxicity
b. Immune response
c. Combination of the two
2. What is the mechanism of injury in chronic viral hepatitis?
a. Immune response more important
3. What are the symptoms of acute viral hepatitis?
a. Fever, malaise, nausea, vomiting
b. Anorexia
c. Jaundice, scleral icterus
d. RUQ pain
e. Hepatomegaly
f. Arthritis
4. What are the lab indications of liver pathology?
a. Elevated ALT and AST
b. Elevated bilirubin-- conjugated
c. Elevated ALP
a. What is the incubation period of Hep A?
i. 30 days
b. What are the complications of Hep A?
i. Fulminant hepatitis
ii. Cholestatic hepatitis
iii. Relapsing hepatitis
c. What immunoglobulin is present in the acute phase of Hep A infection?
i. IgM
d. Who should get a Hep A vaccination?
i. Children older than 1
ii. Working in endemic areas
iii. Traveling to endemic areas
e. How should get Hep A immune globulin pre-exposure?
i. Travelers to intermediate and high HAV-endemic regions
f. What is the window for post-exposure use of HAV immune globulin?
i. 14 days
a. What is the incubation period of Hep B?
i. 60-90 days
b. What is the presentation of chronic persistent HBV hepatitis?
i. Asymptomatic
c. What is the presentation of chronic active HBV hepatitis?
i. Symptomatic exacerbations of hepatitis
d. What are the manifestations of Hep B disease?
i. Chronic persistent hepatitis
ii. Chronic active hepatitis
iii. Cirrhosis
iv. Hepatocellular carcinoma
e. During what period is HBsAg present in someone recovering from HBV?
i. 4-24 weeks
f. When do anti-HBs antibodies show up in someone recovering from HBV?
i. 32 weeks
g. During what period is IgM anti-HBc present in someone recovering from HBV?
i. 4-32 weeks
h. When is the “window period” of an HBV infection?
i. 24-32 weeks
ii. Between HBsAG cessation and anti HBs appearance
i. What is the serological proof that someone is “cured” of HBV?
i. Antibodies to both core and surface of HBV
j. When is HBeAg present in someone recovering from HBV?
i. 4-12 weeks
k. When does total anti-HBc appear in someone recovering from HBV?
i. 4 weeks
ii. Continues permanently
l. During what period is IgM anti-HBc present in progression to chronic HBV infection?
i. 6-36 weeks
a. During what period I HBsAg present in progression to chronic HBV infection?
i. Permanently
n. What % of infant cases of HBV go chronic?
i. 90%
o. Where is HBV most highly concentrated?
i. Blood
ii. Serum
iii. Wound exudates
p. Where is HBV found moderately concentrated?
i. Semen
ii. Vaginal fluid
iii. Saliva
q. Where is HBV low/not detectable
i. Urine
ii. Feces
iii. Sweat
iv. Tears
v. Breastmilk
r. How is HBV transmitted?
i. Sexually
ii. Parenterally
iii. Perinatally
s. What is the goal of HBV treatment?
i. Remission of liver disease
a. How does INFα work?
i. Suppresses replication
ii. Induces remission
b. How is INFα administered?
i. Subcutaneous injections
ii. 6-12 months
c. What is the MOA of nucleosides? What are some examples?
i. Make virus unable to replicate-- does not prevent all viral replication
ii. Lamivudine, adefovir, entecavir, telbivudine
d. What is a drawback of nucleosides?
i. Resistance can be developed very quickly
a. When should children get the HBV vaccine?
i. 1st dose at birth
ii. 2nd dose at 1-2 months of age
iii. 3rd dose at 6-18 months of age
b. When should adults get the HBV vaccination?
i. 1st dose whenever
ii. 2nd dose 4 weeks after the first
iii. 3rd dose 5 months after the second
a. What is the incubation period of HCV?
i. 6-7 weeks
b. What are the risk factors for transmission of HCV?
i. Transfusion or transplant
ii. Injected drug use
iii. Hemodialysis
iv. Needles/sharps injury
v. Sexual/household exposure
vi. Multiple sex partners
vii. Vertical transmission
c. What is the use of the HCV antibody?
i. Dx HCV
ii. Not useful in acute phase
d. What is the use of HCV antigen?
i. Dx acute phase of HCV
ii. Measure response to therapy
e. What is the use of HCV-RNA?
i. Dx acute phase of HCV
ii. Measure response to therapy
f. What is the goal of HCV treatment?
i. Prevent complications and death
ii. Sustained virological response at 24 weeks
g. Who should you NOT treat for HCV?
i. Major uncontrolled depressive illness
ii. Solid organ transplant
iii. Autoimmune hepatitis
iv. Untreated thyroid disease
v. Pregnant or unwilling to comply with contraception
vi. Other major medical issue
vii. Age less than 2 years
h. What medications are used to treat HCV?
i. INFα and ribavirin
i. What determines the dosing of ribavirin?
i. Weight
j. How long should INFα and ribavirin be given to treat genotype I of HCV?
i. 1-48 weeks
k. How long should INFα and ribavirin be given to treat genotypes II and III of HCV?
i. 24 weeks
l. What is a rapid virological response?
i. Undetectable HCV RNA at week 4 of treatment
m. What is an early virological response?
i. A 2 log reduction or complete absence of serum HCV RNA at week 12 of therapy compared with baseline level
a. Who is most at risk for autoimmune hepatitis?
i. Middle-aged or teenage women
ii. Non-drinker
iii. No viral hepatitis
b. What are the symptoms of autoimmune hepatitis?
i. Fatigue
ii. Arthralgias/myalgias
iii. Oligomenorrhea
iv. Jaundice
c. What are the lab markers for autoimmune hepatitis?
i. AST/ALT increase
ii. Gamma globulins
iii. Positive ANA and SMA
d. How can you treat autoimmune hepatitis?
i. Corticosteroids
a. What is the dx determinant of primary biliary cirrhosis?
i. Isolated elevation of ALP
ii. POSITIVE AMA
b. For what are you at risk if you have primary biliary cirrhosis?
i. Hepatocellular carcinoma
a. How can you dx primary sclerosing cholangitis/
i. Elevated ALP
ii. Negative for AMA
iii. Closely linked to UC